BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lerner A, Benzvi C. Checkpoint Inhibitors and Induction of Celiac Disease-like Condition. Biomedicines 2022;10:609. [DOI: 10.3390/biomedicines10030609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shimu AS, Wei H, Li Q, Zheng X, Li B. The new progress in cancer immunotherapy. Clin Exp Med. [DOI: 10.1007/s10238-022-00887-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Albarrán-artahona V, Laguna J, Gorría T, Torres-jiménez J, Pascal M, Mezquita L. Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy. Diagnostics 2022;12:2091. [DOI: 10.3390/diagnostics12092091] [Reference Citation Analysis]
3 Aloisi F, Veroni C, Serafini B. EBV as the 'gluten of MS' hypothesis: Bypassing autoimmunity. Mult Scler Relat Disord 2022;66:104069. [PMID: 35908445 DOI: 10.1016/j.msard.2022.104069] [Reference Citation Analysis]